| Code | Description | Claims | Beneficiaries | Total Paid |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,401 |
1,284 |
$59K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,807 |
2,736 |
$47K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,829 |
1,671 |
$44K |
| 80061 |
Lipid panel |
2,739 |
2,670 |
$37K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,427 |
4,162 |
$35K |
| 80053 |
Comprehensive metabolic panel |
3,223 |
3,085 |
$34K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
388 |
374 |
$19K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,376 |
1,346 |
$14K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
394 |
381 |
$12K |
| 81001 |
|
3,091 |
3,010 |
$10K |
| 86328 |
|
504 |
476 |
$10K |
| 36415 |
Collection of venous blood by venipuncture |
743 |
671 |
$5K |
| 86703 |
|
343 |
334 |
$4K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
68 |
66 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
69 |
67 |
$3K |
| 87400 |
|
134 |
130 |
$3K |
| 82043 |
|
426 |
419 |
$3K |
| 80074 |
|
40 |
39 |
$2K |
| 86738 |
|
109 |
105 |
$2K |
| 81000 |
|
363 |
326 |
$1K |
| 82274 |
|
71 |
70 |
$1K |
| 84436 |
|
164 |
163 |
$1K |
| 84479 |
|
137 |
135 |
$892.58 |
| 82570 |
|
132 |
128 |
$690.76 |
| 84153 |
|
38 |
38 |
$661.68 |
| 86592 |
|
121 |
119 |
$545.50 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
15 |
14 |
$127.28 |
| 87088 |
|
14 |
14 |
$119.63 |
| 84439 |
|
12 |
12 |
$115.81 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
12 |
12 |
$106.59 |
| 82270 |
|
27 |
27 |
$92.04 |
| 85651 |
|
12 |
12 |
$41.22 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
28 |
26 |
$0.00 |